Nordson Corporation
NASDAQ: NDSN
Stock price
309.99 USD
(+0%) TODAY
Financial Performance
5Y price score: 47
The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.
A score of 100 indicates that the stock did as well as the S&P 500 Index.
A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.
10Y return: 262.9%
US$ Per
Share
By default your notes are visible only to you.
211.5
52-week range
315.6
Your model inputs
Your fair value & Margin of safety
To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.
Forecast:
Valuation
Free Cash Flow Yield
4.1 %
Dividend Yield TTM
1.1 %
Market cap $
$ 17,272
Price / Earnings TTM
33.1
Price / Book TTM
5.4
PEG TTM
6.7
Earnings growth and return
LTM
5YR
10YR
Total return (price & dividends)
41.3 %
41.1 %
262.9 %
Free cash flow per share growth
36.1 %
50.3 %
255.4 %
Earnings per share growth
4.9 %
99.3 %
146.7 %
Business Summary:
Latest Earnings Call Takeaways
2026 Q2 (May 21, 2026)
1) Strong Financial Performance - Record sales of $741 million, an 8% YoY increase, with 7% organic growth. - EBITDA reached $235 million, representing 32% of sales, also a second quarter record. - Adjusted earnings per share hit $2.86, an 18% increase YoY. - Free cash flow of $170 million, with over 100% conversion of net income.
2) Segment Highlights and Growth Drivers - Industrial Precision Solutions: Sales of $350 million, up 10% YoY; organic growth of 5%. - Medical and Fluid Solutions: Sales of $213 million, up 5% YoY; organic growth of 8% despite divestiture impacts. - Advanced Technology Solutions: Sales of $178 million, a 10% increase YoY; strong demand in semiconductor applications.
3) Strategic Acquisitions and Market Positioning - Acquisition of CapstanAG, enhancing precision agriculture capabilities, valued at 9x adjusted EBITDA. - Focus on diversifying the portfolio with over 50% in growth end markets such as semiconductor and medical. - Strong order entry momentum with 18% increase in backlog across all segments.
4) Guidance and Outlook - Q3 sales guidance set between $760 million to $790 million; adjusted earnings forecasted at $2.95 to $3.15 per share. - Full-year sales expected between $2.930 billion to $3.010 billion; adjusted earnings between $11.30 to $11.80 per share. - Confidence in guidance supported by strong order entry and backlog, with potential for upper-end performance if demand trends continue.
5) Challenges and Considerations - Inflationary pressures impacting margins, particularly in the Industrial Precision Solutions segment. - Regulatory changes causing temporary operational inefficiencies in medical product lines. - Potential macroeconomic headwinds could affect future performance, though current demand patterns remain strong.
Bottom line: Nordson Corporation's strong Q2 performance, driven by robust organic growth across all segments and strategic acquisitions, positions the company well for continued success. The positive outlook for the remainder of the year, supported by a healthy backlog and disciplined capital deployment, makes Nordson an attractive investment for shareholders.
Annual Reports, Presentations And IR Contacts
Go to the websiteNordson Corporation — Financial Overview, Stock Price, Market Cap
Nordson Corporation is a company. Founded in 1935. As of August 14, 2026, the company's market capitalization is $17272022820 with a current stock price of $309.99.
